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ABSTRACT
OBJECTIVES
To investigate whether further centralisation of acute 
stroke services in Greater Manchester in 2015 was 
associated with changes in outcomes and whether 
the effects of centralisation of acute stroke services in 
London in 2010 were sustained.
DESIGN
Retrospective analyses of patient level data from the 
Hospital Episode Statistics (HES) database linked to 
mortality data from the Office for National Statistics, and 
the Sentinel Stroke National Audit Programme (SSNAP).
SETTING
Acute stroke services in Greater Manchester and 
London, England.
PARTICIPANTS
509 182 stroke patients in HES living in urban areas 
admitted between January 2008 and March 2016; 
218 120 stroke patients in SSNAP between April 2013 
and March 2016.
INTERVENTIONS
Hub and spoke models for acute stroke care.
MAIN OUTCOME MEASURES
Mortality at 90 days after hospital admission; length 
of acute hospital stay; treatment in a hyperacute 
stroke unit; 19 evidence based clinical interventions.
RESULTS
In Greater Manchester, borderline evidence suggested 
that risk adjusted mortality at 90 days declined 
overall; a significant decline in mortality was seen 
among patients treated at a hyperacute stroke unit 
(difference-in-differences −1.8% (95% confidence 
interval −3.4 to −0.2)), indicating 69 fewer deaths per 
year. A significant decline was seen in risk adjusted 
length of acute hospital stay overall (−1.5 (−2.5 to 
−0.4) days; P<0.01), indicating 6750 fewer bed days a 
year. The number of patients treated in a hyperacute 
stroke unit increased from 39% in 2010-12 to 86% 
in 2015/16. In London, the 90 day mortality rate was 
sustained (P>0.05), length of hospital stay declined 
(P<0.01), and more than 90% of patients were treated 
in a hyperacute stroke unit. Achievement of evidence 
based clinical interventions generally remained 
constant or improved in both areas.
CONCLUSIONS
Centralised models of acute stroke care, in which 
all stroke patients receive hyperacute care, can 
reduce mortality and length of acute hospital stay 
and improve provision of evidence based clinical 
interventions. Effects can be sustained over time.
Introduction
Stroke is a leading cause of mortality and disability.1 
A wealth of evidence shows that organised care in 
an inpatient stroke unit is associated with better 
quality of care and reduced death and dependency.2-4 
Evidence also suggests that variation exists within 
and between countries in both access to stroke unit 
care and organisational models within stroke units,5 6 
which affects access to rapid diagnosis and treatment, 
secondary prevention, and rehabilitation.7 In several 
countries, acute stroke services are being centralised 
into “hub and spoke” systems as a means of improving 
access to organised care in inpatient stroke units. 
Hospitals providing different levels of stroke care work 
together to create a centralised system,8 in which all 
patients in the system with acute stroke are taken 
to central specialist units rather than the nearest 
hospital, with a larger number of hospitals providing 
care beyond the acute phase. Research in several 
countries including the US, Canada, the Netherlands, 
Denmark, and Australia suggests that this approach 
may improve provision of evidence based care 
processes for all stroke patients, by increasing 
access to specialist care and thrombolysis where 
appropriate.9-14 Although improved clinical outcomes 
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among patients admitted to organised inpatient stroke 
care are well documented, relatively little evidence 
exists to show whether centralising acute stroke care 
to a small number of high volume specialist centres 
produces better clinical outcomes at the system level 
across all stroke patients.15 16 Our previous research 
showed reductions in mortality after the centralisation 
of stroke services in London (see below). A recent 
study found that centralisation in the Central Denmark 
Region significantly reduced length of acute hospital 
stay without compromising quality, and mortality and 
readmissions remained unchanged.17 No studies have 
evaluated longer term sustainability of the effects of 
centralising acute stroke services.
In 2010 acute stroke services were centralised 
across two metropolitan areas of England—Greater 
Manchester (population 2.7 million) and London (8.2 
million).18 Our earlier analysis using data from January 
2008 to March 2012 showed that in London, where 
hyperacute stroke care was provided to all patients, 
a reduction in mortality and length of acute hospital 
stay occurred; in Greater Manchester, where specialist 
hyperacute stroke care was provided only to patients 
presenting within four hours of developing stroke 
symptoms, no effect on mortality was seen but length of 
hospital stay decreased.19 We also showed that patients 
treated at hyperacute stroke units (HASUs) in Greater 
Manchester and London were significantly more likely 
to receive evidence based interventions than those 
treated at other units.20 In Greater Manchester, 39% 
of stroke patients were admitted to a HASU, compared 
with 93% in London, possibly explaining the difference 
in mortality outcomes between the two areas. Both 
centralisations had a high probability of being cost 
effective.21 Other research has shown that outcomes 
for patients treated at HASUs in London improved after 
the centralisation, whereas outcomes worsened for 
those in London not treated at HASUs22; differences in 
in-hospital mortality between weekday and weekend 
admissions fell in London between 2008 and 2014, 
but this was not related to the centralisation23; and the 
centralisation in London was cost effective.24
In Greater Manchester, further centralisation of the 
acute stroke system was implemented in April 2015; 
also, few data are available on the sustainability of 
the effects of centralising acute stroke services. Given 
this, plus the growing interest in reconfiguration of 
services generally,25 we extended our original analyses 
with new data covering the period to March 2016. 
The aims of this study were to investigate whether 
the further centralisation of acute stroke services in 
Greater Manchester in 2015 had an effect on outcomes 
and whether the effects of the 2010 centralisation in 
London were sustained over an additional four years 
(2012-16). We also analysed provision of evidence 
based interventions, as these may explain outcomes.20
Methods
The centralisations
Before the centralisations, in both London and Greater 
Manchester, patients with suspected stroke were taken 
to the nearest emergency department to receive stroke 
care and then treated on a stroke unit or general ward 
(fig 1, first panel). After the centralisation in London in 
2010, 24/7 specialist care was provided to all patients 
in eight designated HASUs. All patients with suspected 
stroke (having a deficit on one or more of the face, 
arm, and speech elements of the FAST test) were taken 
by the London Ambulance Service to the HASU that 
involved the shortest journey time (no more than 30 
minutes away). The appropriate HASU for a particular 
postcode may change depending on traffic conditions. 
Ambulance staff may not necessarily transport 
patients to the nearest HASU depending on capacity 
issues. On arrival at the HASU, patients are assessed 
immediately by specialised stroke medical teams 
capable of rapid brain imaging and thrombolysis when 
appropriate. Patients are then admitted to a HASU 
bed where they receive hyperacute care for up to 72 
hours after admission. Once patients are stabilised, 
they are either transferred to one of 24 stroke units 
that provide acute rehabilitation services and ongoing 
medical supervision or discharged home and receive 
community rehabilitation services (fig 1, second 
panel).18 The location of the stroke unit that patients 
are taken to depends on their postcode of residence; 
patients are usually transferred to a stroke unit close to 
their home, which may be in the same hospital as the 
HASU. Length of stay in the stroke unit varies, lasting 
until the patient is well enough to be discharged from 
an acute inpatient setting. Following their stay in 
the stroke unit, patients are discharged home or to a 
specialist inpatient facility for long term rehabilitation. 
After the 2010 reconfiguration in Greater Manchester 
(until 2015), patients presenting within four hours 
of developing stroke symptoms were taken directly 
to a HASU (one 24/7 HASU called a comprehensive 
stroke centre (CSC) and two HASUs running 7am-7pm, 
Monday-Friday (primary stroke centres; PSCs)); all 
other patients were taken to one of 10 district stroke 
centres (DSCs), designated to provide all aspects of 
post-thrombolysis stroke care (fig 1, third panel).26 
After the 2015 centralisation in Greater Manchester, all 
patients were eligible for treatment in a HASU rather 
than just those arriving at hospital within four hours, 
and the two HASUs operating “in hours” extended 
the hours in which they would admit stroke patients 
(7am-11pm, Monday-Sunday) (fig 1, fourth panel). 
The HASUs in Greater Manchester operate similarly to 
those in London.
Data
Analysis of mortality and length of acute hospital 
stay
To investigate mortality and length of acute hospital 
stay, we obtained patient level data from the Hospital 
Episode Statistics (HES) database for all patients in 
England with a primary diagnosis of stroke defined using 
international classification of diseases, 10th revision 
(ICD-10) codes I61 (intracerebral haemorrhage), I63 
(cerebral infarction), or I64 (stroke, not specified as 
haemorrhage or infarction, which usually refers to 
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cases in which the cause of the stroke has not been 
documented in the medical record) between 1 January 
2008 and 31 March 2016 (that is, 33 quarters/99 
months).27 We excluded subarachnoid haemorrhage 
(ICD-10 code I60) as it is managed through a different 
clinical pathway.28 The dataset was confined to patients 
living in urban areas (defined as “urban-less sparse” 
using the urban/rural classification for England).29 We 
linked the data to mortality data supplied by the Office 
for National Statistics,30 using an anonymised unique 
patient identifier to identify deaths from any cause 
and at any place of death (hospital or otherwise) by 90 
days after hospital admission. We measured length of 
acute hospital stay (HASU plus stroke unit stay) in days 
as the difference between date of admission and date 
of discharge, including same day transfers between 
hospitals. We created regional variables to identify 
whether the hospital trust the patient was admitted 
to was in London, Greater Manchester, or the rest of 
England. The start of our analysis period was January 
2008, following the publication of the National Stroke 
Strategy for the English NHS in December 2007.31 The 
centralisations in Greater Manchester were completed 
in April 2010 and March/April 2015. The centralisation 
in London began to be implemented in October 2009 
and was fully operational in July 2010. Data were 
available for 509 182 admissions, of which 34 051 
were in Greater Manchester (9412 from January 2008 
to March 2010, 20 390 from April 2010 to March 
2015, 4249 from April 2015 to March 2016), 69 847 
were in London (18 654 before the centralisation, 
51 193 after), and 405 284 were for the rest of England. 
Mortality data for our analysis were complete; we 
dropped 17 411 (3%) observations from the analysis 
of length of acute hospital stay because admission or 
discharge data were missing (4207 observations) or the 
acute hospital stay lasted more than 120 days (13 204).
Analysis of evidence based clinical interventions
To investigate evidence based clinical interventions, 
we used patient level data collected for the clinical 
audit component of the Sentinel Stroke National Audit 
Programme (SSNAP),32 organised by the Royal College 
of Physicians. Our data covered the period 1 April 2013 
to 31 March 2016 and included data submitted by 
every stroke unit in England. We examined whether the 
patient was treated in a HASU, plus 19 binary clinical 
interventions (measured from time of hospital arrival 
or onset of stroke symptoms for patients who were 
already in hospital): brain scan within 60 minutes, 180 
minutes, or 24 hours; administration of intravenous 
thrombolysis (tissue plasminogen activator) if eligible, 
and whether it was given within 60 minutes; swallow 
screen within four hours; admission to a stroke unit 
within four hours; assessment by a stroke consultant 
physician within 14 hours or 24 hours; assessment 
by a stroke nurse within 12 hours or 24 hours; 
assessment by a specialist physiotherapist within 24 
hours or 72 hours; assessment by an occupational 
therapist within 24 hours or 72 hours; formal swallow 
assessment by a speech and language therapist within 
24 hours or 72 hours; and communication assessment 
by a speech and language therapist within 24 hours 
or 72 hours. These measures are quality interventions 
routinely reported by SSNAP. Data were available for 
218 120 admissions, of which 12 086 were in Greater 
Manchester (7606 from April 2013 to March 2015, 
4480 from April 2015 to March 2016), 24 281 were in 
London, and 181 753 were for the rest of England.
Statistical analyses
We evaluated whether the 2015 centralisation of acute 
stroke services in Greater Manchester had an effect 
on mortality and length of hospital stay by using a 
between region difference-in-differences regression 
analysis comparing the change over time in Greater 
Manchester with the change over time in the rest of 
England (controlling for outcomes in London). We 
did the analysis at hospital level, using monthly 
observations of risk adjusted mortality and length 
of hospital stay. The risk adjustment was done at the 
patient level. We calculated expected risks of death 
at 90 days after admission by using patient level 
logistic regressions, including binary indicators for 
sex and age interactions (age measured in five year 
bands), stroke diagnosis using the first four digits of 
the primary ICD-10 diagnostic code (19 categories), 
number of comorbidities derived from secondary ICD-
10 diagnostic codes, presence of 16 comorbidities 
based on ICD-10 chapter headings derived from 
secondary ICD-10 diagnostic codes, ethnic group 
(19 categories), and fifth of deprivation of the lower 
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Fig 1 | Simplified pre-centralisation and post-centralisation models in London and Greater Manchester. First panel: before 2010 centralisations in 
London and Greater Manchester. Second panel: after 2010 centralisation in London. Third panel: after 2010 centralisation in Greater Manchester 
until 2015. Fourth panel: after 2015 centralisation in Greater Manchester. CSC=comprehensive stroke centre; DSC=district stroke centre; 
HASU=hyperacute stroke unit; PSC=primary stroke centre.
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layer super output areas in which the patient lived.33 
We ran the patient level regressions only for patients 
who had a stroke before the centralisations so that 
risk adjustment was not contaminated by the changes. 
We used the regression coefficients (derived from the 
logistic regressions for the pre-implementation period) 
to predict the probability of mortality for every patient 
(in both pre-implementation and post-implementation 
periods). We aggregated these to create a dataset of 
the actual percentage of patients who died and the 
expected percentage by admitting hospital and month. 
We tested whether the 2015 centralisation had an 
effect on mortality by using least squares regression 
of the actual minus expected mortality percentage 
against interaction terms between Greater Manchester 
and the post-April 2015 centralisation period. We 
included binary indicators for admitting hospital 
(520 hospital fixed effects) and month (99 time fixed 
effects), as well as an interaction term between London 
and the post-July 2010 London centralisation period to 
control for the effects of the London reconfiguration. 
We used a similar method in our previous study,19 
and before that it was used in an evaluation of the 
advancing quality initiative in the north west of 
England.34 Some hospitals began to reconfigure their 
services before April 2015, and we controlled for 
this in our analysis by using hospital and time fixed 
effects. We did not include a separate interaction 
term for the April 2010 centralisation in Greater 
Manchester because our previous analysis showed 
no effect of this reconfiguration on mortality. Each 
observation was weighted by the number of patients 
treated at that hospital in that month. We re-ran the 
second stage of the difference-in-differences analysis 
including an interaction term only for the HASUs and 
the post-centralisation period (note that the primary 
stroke centres were not 24/7 HASUs, but data on time 
of arrival at the hospital were not available so the 
analysis included all patients treated at these hospitals 
irrespective of when they arrived). We ran all of the 
above separately for stroke diagnoses (ICD-10 codes 
I61, I63, and I64).
We used the same approach for length of hospital 
stay in Greater Manchester, but our risk adjustment 
equation was estimated using a generalised linear 
model with γ family and log link to account for data 
skewness.35 We also added binary indicators for 
mortality at three, 30, and 90 days after stroke to the 
risk equation and used the regression coefficients to 
predict expected mean length of acute hospital stay. We 
included a separate interaction term for the pre-April 
2010 centralisation in Greater Manchester because 
our previous analysis showed a significant effect of 
the 2010 centralisation on length of hospital stay; 
our comparison was therefore of the change in length 
of stay following the second centralisation compared 
with the first.
To analyse whether the effects of the 2010 
centralisation in London were sustained over the 
period 2012-16, using patient level data for London 
only we regressed 90 day mortality against the 
covariates used in the risk adjustment model described 
above, plus hospital and month. We used logistic 
regression analysis. We then calculated the predictive 
margins of month on mortality and plotted these on a 
graph. We tested for significant variations in adjusted 
mortality since the centralisation by using Wald 
tests, and we present the results as P values under 
the null hypothesis that the regression coefficient 
for every month after the centralisation (which was 
fully operational from July 2010) was the same as the 
regression coefficient for July 2010. In the analysis of 
length of hospital stay in London, we used a similar 
approach except that we used the generalised linear 
model as above and also controlled for mortality at 
three, 30, and 90 days.
For the analysis of the evidence based clinical 
interventions, we used all data submitted across 
England and regressed whether or not each of the 
clinical interventions had been achieved against sex, 
age (measured in five year bands), stroke diagnosis 
(cerebral infarction or intracerebral haemorrhage), 
whether the stroke happened inside or outside 
hospital, and worst level of consciousness on arrival 
at the hospital (alert, verbally arousable, not alert, or 
totally unresponsive).36 We used logistic regression 
analysis and included interactions terms between time 
period (1 April 2013 to 31 March 2014, 1 April 2014 to 
31 March 2015, 1 April 2015 to 31 March 2016) and 
region (Greater Manchester, London, rest of England), 
and we calculated predictive margins for each of these 
interaction terms to give the adjusted probability that 
each clinical intervention would be achieved in each 
region and year, controlling for the covariates. We 
did not include hospital fixed effects as these were 
perfectly correlated with region. In Greater Manchester, 
we were interested in whether achievement of the 
clinical interventions improved in the third year 
of our data beyond the changes seen in the rest of 
England. In London, we were interested in whether the 
achievement of the clinical interventions was constant 
over the three year period. For comparison, we present 
the findings alongside the results of our original 
analyses covering the period 2010-12, which included 
fewer clinical interventions.20
Patient and public involvement
This study was supported by a patient and families 
research advisory group that was consulted on 
the original research question and methods for 
disseminating the outputs of this study. We also 
presented findings from previous analyses done as part 
of this study to these groups to ensure that we were 
addressing questions and communicating lessons in a 
meaningful way. The findings of this research will be 




Across all stroke types combined, unadjusted mortality 
at 90 days in Greater Manchester fell by 3.1 percentage 
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points after the April 2015 centralisation; in the rest 
of England, the reduction was 2.0% (table 1). The 
unadjusted between region difference-in-differences 
indicate an additional 1.1% reduction in 90 day 
mortality in Greater Manchester over and above the 
reduction seen in the rest of England.
We found borderline evidence of adjusted between 
region difference-in-differences in 90 day mortality in 
Greater Manchester across all types of stroke combined 
(95% confidence interval −2.7 to 0.01; table 2). When 
we re-ran the analysis only for patients treated at a 
HASU (86% of all stroke patients, see below), we saw a 
1.8% (−3.4 to −0.2) reduction in 90 day mortality (table 
2); the coefficient was larger (more negative) than in 
the all hospital model and significantly different from 
zero. Assuming an estimated 4500 strokes in Greater 
Manchester each year (see above), and that 86% of 
these were treated in a HASU (see below), the mortality 
reduction is consistent with 69 fewer deaths per year 
(4500×0.86×−1.8/100).
Values in difference-in-differences columns are 
absolute differences in risk adjusted mortality showing 
change over time in Greater Manchester minus 
change over time in rest of England (see text). Values 
in preceding columns show absolute risk adjusted 
mortality in rest of England, Greater Manchester, 
and Greater Manchester HASUs. To estimate these, 
separate models were run for rest of England, Greater 
Manchester, and Greater Manchester HASUs. Patient 
level data were used to regress mortality against sex 
and age interactions, stroke diagnosis using first four 
digits of primary ICD-10 diagnostic code, number 
of comorbidities derived from secondary ICD-10 
diagnostic codes, presence of 16 comorbidities based on 
ICD-10 chapter headings derived from secondary ICD-
10 diagnostic codes, ethnic group, fifth of deprivation, 
hospital and calendar month, plus indicator variables 
for whether patient was admitted before or after April 
2015 reconfiguration in Greater Manchester; predictive 
margins for this indicator variable are shown in table. 
Values in difference-in-differences columns do not 
equal differences in absolute risk adjusted mortality 
in preceding columns: with statistical method used to 
estimate difference-in-differences (see text), it is not 
possible to recover absolute risk adjusted mortality 
levels directly.
In Greater Manchester, mean unadjusted length of 
acute hospital stay across all stroke types was 17.4 
days between April 2010 and March 2015 and 14.4 
days after the 2015 centralisation; figures in the rest 
of England were 18.1 days and 15.7 days, respectively 
(table 3). The unadjusted between region difference-
in-differences in length of hospital stay was −0.6 days.
Across all stroke types, we found a significantly 
larger decline in risk adjusted length of acute hospital 
stay in Greater Manchester compared with the rest of 
England, by 1.5 (−2.5 to −0.4) days (table 4). If this 
reduction was applied to the estimated 4500 patients 
with a stroke in Greater Manchester each year, this 
would result in 6750 fewer bed days a year.
We re-ran our models on patients stratified by type of 
stroke (see supplementary table A for further details of 
the numbers of patients with each type of stroke in each 
time period and region), and found that reductions 
in mortality and length of hospital stay were largely 
achieved among patients diagnosed as having cerebral 
infarction (table 2 and table 4), who were the majority 
of cases (supplementary table A). For length of acute 
hospital stay, the largest decline was in the I64 (stroke 
unspecified) subgroup, which may be a function of 
better access to diagnostic testing on arrival at the 
hospital (especially in patients admitted to a HASU), 
and, as a consequence of this, declining numbers of 
patients falling into this group (supplementary table 
A). Mortality and length of stay outcomes for patients 
with intracerebral haemorrhage were non-significant, 
possibly owing to the relatively small numbers of 
patients in the subgroup (supplementary table A).
In London, we found no significant variation in 
mortality at 90 days over time since the centralisation 
(P=0.09; fig 2). Length of acute hospital stay since the 
centralisation significantly declined (P<0.01; fig 3).
Treatment in hyperacute stroke unit
In Greater Manchester, the percentage of patients 
treated in a HASU increased from 39% in 2010-12 to 
57% in 2013/14, to 64% in 2014/15, and to 86% in 
2015/16 (supplementary table B). Equivalent figures 
for patients in London treated in a HASU were 93%, 
95%, 94%, and 94%, respectively.
Evidence based clinical interventions
In Greater Manchester, achievement of evidence based 
clinical interventions after the 2015 centralisation 
either stayed the same or improved compared with 
the previous two years (table 5). Improvements of 
Table 1 | Unadjusted between region difference-in-differences in mortality at 90 days (all stroke types; Greater 
Manchester versus rest of England, excluding London)
Analysis No of admissions Mortality (%)
Rest of England (January 2008 to March 2015) 356 841 23.3
Rest of England (April 2015 to March 2016) 48 443 21.3
Greater Manchester (January 2008 to March 2015) 29 802 22.7
Greater Manchester (April 2015 to March 2016) 4249 19.6
Differences:
 Rest of England (April 2015 to March 2016) minus (January 2008 to March 2015) - −2.0
 Greater Manchester (April 2015 to March 2016) minus (January 2008 to March 2015) - −3.1
Difference-in-differences:
 Greater Manchester minus rest of England - −1.1
Values are based on proportion of patients who died in each region in each time period.
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greater than 10% occurred for several “front door” 
processes (brain scan within 60 minutes, admitted to 
a stroke unit within four hours) and assessments over 
the first 72 hours (assessment by a stroke consultant 
physician within 14 and 24 hours, assessment by a 
specialist physiotherapist with 24 hours, assessment 
by an occupational therapist within 24 hours, and 
communication assessment by a speech and language 
therapist within 24 hours). Improvements and levels 
of achievement in the rest of England during the same 
time period were either similar to or lower than those 
seen in Greater Manchester. In London the “front door” 
processes, use of thrombolysis, and assessments during 
the first 72 hours all stayed high and constant over the 
three years with no more than a 5% fluctuation each 
year (table 6). The percentage of patients admitted 
to a stroke unit within four hours and the percentage 
having a formal swallow assessment by a speech and 
language therapist within 72 hours fell by 5-10%. We 
identified similar trends when we used unadjusted 
data (supplementary tables C-E).
Discussion
After the further centralisation of stroke care in Greater 
Manchester in 2015, a larger proportion of patients 
were treated in a HASU (comprehensive stroke centre 
or primary stroke centre) than in 2010. Achievement of 
evidence based clinical interventions either stayed the 
same or improved compared with the rest of England. 
A decline in mortality from stroke occurred after the 
centralisation, and we found borderline evidence that 
a reduction in mortality occurred across all hospitals 
in Greater Manchester over and above the changes 
seen in the rest of England. A reduction in all cause 
mortality was seen in the HASUs that was statistically 
significantly larger than the reductions seen elsewhere 
and would amount to approximately 69 fewer deaths a 
year. A significant reduction in length of hospital stay 
of 1.5 days per patient was seen in Greater Manchester 
over and above the reduction seen in the rest of England, 
which would amount to approximately 6750 fewer 
bed days a year. In the analysis for London, mortality 
and evidence based clinical interventions seem to 
have varied little over time since the centralisation 
in July 2010. Length of acute hospital stay since the 
centralisation significantly declined. This indicates 
that the improvements seen after the centralisation in 
London have largely been sustained, with reductions 
in performance in some clinical interventions and 
further declines in length of acute hospital stay.
Strengths and weaknesses of study
The strengths and weakness are similar to those of our 
earlier studies.19 20 The strengths relate to the large 
national datasets and the robust quasi-experimental 
analytical frameworks that we used. In addition, 
our data covered a longer time period allowing us to 
investigate the effect of further changes in Greater 
Manchester and whether the improvements in London 
seen in 2010 to 2012 were maintained over time.
The main limitation is lack of data on severity of 
stroke; these data are not available in the HES database. 
If stroke patients were more likely to die before reaching 
the HASU owing to longer travel distances, or if more 
patients with less severe strokes were likely to go to 
hospital after centralisation, this would mean that the 
level of stroke severity on arrival at the hospital would 
be different before and after centralisation. As shown in 
the supplementary material, no discernible differences 
existed in indicators of stroke severity (worst level of 
consciousness in first 24 hours after stroke) over time 
in patients admitted to hospital in Greater Manchester 
and London. Nevertheless, we cannot rule out the 
possibility that our findings are due to variations in 
stroke severity between Greater Manchester, the rest of 
England, and London over time.
Another limitation is that we were unable to include 
other important outcomes such as disability. Data on 
disability and dependence are collected in SSNAP at 





















Jan 2008 Jan 2010 Jan 2012 Jan 2014 Jan 2016
Fig 2 | Adjusted trends in mortality at 90 days in London. Note that y axis does not start 
at zero. Vertical line indicates when centralisation in London was fully operational (July 
2010), although centralisation began to be implemented in October 2009. P value 
(under null hypothesis that regression coefficient for every month after centralisation 
(which occurred in July 2010) is same as regression coefficient for July 2010) is 0.09
Table 2 | Adjusted between region difference-in-differences (Greater Manchester versus rest of England and HASUs in Greater Manchester versus rest 
of England, controlling for London). Values are absolute differences in risk adjusted mortality at 90 days after admission
Type of stroke
Rest of England Greater Manchester HASUs in Greater Manchester Difference-in-differences (95% CI)
Before After Before After Before After
Greater Manchester v 
rest of England
HASUs in Greater Manchester v 
rest of England
All stroke types 23.4 20.8 22.8 18.6 23.5 18.4 −1.3 (−2.7 to 0.01) −1.8 (−3.4 to −0.2)
Intracerebral haemorrhage (I61*) 41.9 43.4 42.6 39.7 43.1 39.9 −4.1 (−8.4 to 0.2) −5.0 (−10.3 to 0.4)
Cerebral infarction (I63*) 19.9 17.0 19.8 15.8 20.5 15.4 −1.2 (−2.6 to 0.2) −1.9 (−3.6 to −0.3)
Stroke, not specified as 
 haemorrhage or infarction (I64*)
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reliably enough for analysis. Additional limitations 
include lack of data on quality of life, lack of data on 
pre-hospital processes and outcomes, and limitations 
in measurement of length of hospital stay when patients 
may be repatriated between stroke units. Additionally, 
length of acute hospital stay depends on the availability 
of community rehabilitation services and the local 
agreements between acute and rehabilitation services 
on the timing of transmission of stroke patients from 
acute care to rehabilitation. Although we controlled 
for hospital and time specific effects in our analysis, 
the decrease in length of acute hospital stay may be 
explained by arrangements for earlier transmission 
of patients to rehabilitation units from acute stroke 
services. In addition, the primary stroke centres in 
Greater Manchester were not 24/7 hyperacute stroke 
units, but data on time of arrival at the hospital were 
not available so the analysis included all patients 
treated at these hospitals irrespective of when they 
arrived (that is, we included people who were treated 
at the primary stroke centres even when they were 
not operating as HASUs), which may mean we have 
underestimated the impact of centralisation in Greater 
Manchester. A limitation of our analysis of SSNAP 
data is that achievement of clinical interventions was 
measured from time of arrival at hospital rather than 
from onset of symptoms. Finally, our analysis used 
data only for patients treated up to one year after the 
further centralisation in Greater Manchester.
Strengths and weaknesses in relation to other studies
Our findings extend those of our earlier analyses, 
examining the longer term effects of the centralisation 
in London, whether the further centralisation in 
Greater Manchester was associated with improvements 
in outcomes, and achievement of clinical interventions. 
The improvement in outcomes seen in London has 
been borne out in other studies, although these have 
also shown that outcomes worsened for patients 
treated for acute stroke in London but not in a HASU.22 
Our findings are consistent with a previous analysis 
based on national stroke audit data showing that 
patients admitted to stroke services with higher levels 
of organisation were more likely to receive high quality 
care and to have a reduced risk of death 30 days after 
stroke.2 Our results are also consistent with those of 
a study evaluating the centralisation of acute stroke 
services in Denmark, which used national stroke 
registry data to show that centralisation reduced 
length of hospital stay without compromising quality 
of care.17 These studies are important because both 
were able to control for stroke severity. Our study has 
focused on one model of acute stroke care—centralised 
“hub and spoke” systems—but other models are also 
possible. For example, evidence from a systematic 
review suggests that for patients with ischaemic 
stroke the location of initial thrombolysis treatment 
does not affect outcomes; death and disability rates 
were not significantly different among thrombolysed 
patients starting treatment in non-specialist centres 
versus specialist centres.37 The greater travel times in 
rural areas make centralisation challenging and may 
necessitate other solutions, such as telemedicine; 
in Finland, a decentralised telestroke thrombolysis 
service achieved similar treatment rates and time 
delays for a rural population to those achieved by a 
centralised system for an urban population.38
Meaning of study
Our study provides evidence to support the 
centralisation of acute stroke services in urban areas 
and shows that this service model should include all 
stroke patients in those areas. This is supported by our 
Table 3 | Unadjusted between region difference-in-differences in length of acute hospital stay (all stroke types; Greater Manchester versus rest of 
England, excluding London)
Analysis No of admissions Unadjusted length of hospital stay (mean days)
Rest of England (January 2008 to March 2010) 105 456 21.0
Rest of England (April 2010 to March 2015) 240 369 18.1
Rest of England (April 2015 to March 2016) 47 507 15.7
Greater Manchester (January 2008 to March 2010) 8862 21.7
Greater Manchester (April 2010 to March 2015) 18 994 17.4
Greater Manchester (April 2015 to March 2016) 4054 14.4
Differences:
 Rest of England (April 2015 to March 2016) minus (April 2010 to March 2015) - −2.4
 Greater Manchester (April 2015 to March 2016) minus (April 2010 to March 2015) - −3.0
Difference-in-differences:
 Greater Manchester minus rest of England - −0.6
























Jan 2008 Jan 2010 Jan 2012 Jan 2014 Jan 2016
Fig 3 | Adjusted trends in length of hospital stay in London. Vertical line indicates when 
centralisation in London was fully operational (July 2010), although centralisation 
began to be implemented in October 2009. P value (under null hypothesis that 
regression coefficient for every month after centralisation (which occurred in July 2010) 
is same as regression coefficient for July 2010) is <0.01)
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earlier analysis of the changes in London and Greater 
Manchester, which found that the centralisation in 
London, where most patients were treated in a HASU, 
resulted in reductions in mortality, whereas the 2010 
Greater Manchester centralisation, in which most 
patients were not treated in a HASU, did not. This 
finding is strengthened by our new analysis of the 
further centralisation in Greater Manchester, in which 
most patients were treated in a HASU and which 
showed reductions in mortality. These findings are 
also supported by data presented here showing the 
increasing numbers of patients treated at a HASU in 
Greater Manchester and our analysis of the provision of 
evidence based clinical interventions (that is, that these 
were more likely to be achieved after the centralisation 
in London compared with the first centralisation in 
Greater Manchester, and that achievement significantly 
increased with the further centralisation in Greater 
Manchester and was largely maintained in London).
Our earlier findings on clinical outcomes in London 
and Greater Manchester were presented in the 2014 
NHS Five Year Forward View as evidence of the 
Table 5 | Adjusted percentages of patients receiving clinical interventions in Greater Manchester and rest of England by year. Values are predictive 
margins
Intervention
Greater Manchester: risk to adjusted proportions (95% CI) Rest of England: risk to adjusted proportions (95% CI)
Ramsay* 2013/14 2014/15 2015/16 2013/14 2014/15 2015/16
Brain scan within 
60 min 40.7 (39.1 to 42.2) 49.2 (47.6 to 50.8) 60.8 (59.4 to 62.2) 43.0 (42.6 to 43.4) 44.8 (44.4 to 45.2) 47.6 (47.3 to 48.0)
Brain scan within 
180 min 65.2 (64.3 to 66.2) 74.1 (72.7 to 75.4) 81.7 (80.5 to 82.9) 86.4 (85.4 to 87.3) 70.9 (70.6 to 71.3) 74.0 (73.7 to 74.3) 77.0 (76.7 to 77.3)
Brain scan within 24 h 94.0 (93.5 to 94.4) 95.1 (94.4 to 95.8) 97.1 (96.5 to 97.6) 97.4 (96.9 to 97.9) 94.9 (94.8 to 95.1) 96.0 (95.8 to 96.1) 96.7 (96.6 to 96.8)
tPA to eligible patients 67.9 (63.6 to 72.1) 82.3 (78.1 to 86.5) 88.6 (85.5 to 91.7) 80.6 (79.8 to 81.3) 89.1 (88.5 to 89.7) 91.8 (91.3 to 92.4)
tPA within 60 min 74.4 (69.6 to 79.2) 70.5 (65.1 to 75.8) 74.6 (70.2 to 78.9) 53.1 (52.0 to 54.2) 57.1 (56.0 to 58.1) 59.7 (58.6 to 60.7)
Swallow screen within 
4 h 58.7 (57.1 to 60.3) 63.4 (61.8 to 65.0) 69.2 (67.8 to 70.6) 59.7 (59.3 to 60.1) 63.9 (63.5 to 64.2) 67.7 (67.3 to 68.0)
Admitted to SU within 
4 h 55.9 (54.9 to 57.0) 57.4 (55.8 to 59.1) 58.8 (57.1 to 60.5) 79.1 (77.9 to 80.4) 51.3 (50.9 to 51.7) 52.8 (52.4 to 53.2) 53.4 (53.0 to 53.7)
Consultant assessment 
14 h 57.6 (55.9 to 59.2) 58.9 (57.2 to 60.6) 79.2 (78.0 to 80.4) 50.6 (50.2 to 51.0) 52.1 (51.7 to 52.5) 52.6 (52.2 to 53.0)
Consultant assessment 
24 h 78.2 (76.9 to 79.6) 80.2 (78.9 to 81.5) 93.0 (92.3 to 93.8) 81.1 (80.8 to 81.4) 82.8 (82.5 to 83.1) 84.3 (84.1 to 84.6)
Stroke nurse 
 assessment 12 h 86.4 (85.3 to 87.4) 86.6 (85.5 to 87.7) 91.2 (90.4 to 92.0) 86.5 (86.2 to 86.7) 88.1 (87.8 to 88.3) 89.3 (89.0 to 89.5)
Stroke nurse 
 assessment 24h 93.4 (92.7 to 94.2) 92.8 (92.0 to 93.6) 94.6 (93.9 to 95.2) 93.2 (93.0 to 93.4) 93.9 (93.7 to 94.0) 94.5 (94.4 to 94.7)
Physiotherapist 
 assessment 24 h 55.4 (53.7 to 57.0) 63.2 (61.6 to 64.8) 80.7 (79.5 to 81.9) 55.6 (55.2 to 56.0) 57.1 (56.7 to 57.4) 59.7 (59.3 to 60.1)
Physiotherapist 
 assessment 72 h 92.1 (91.5 to 92.7) 95.1 (94.3 to 95.8) 97.0 (96.4 to 97.6) 97.5 (97.1 to 98.0) 93.6 (93.4 to 93.8) 93.4 (93.2 to 93.6) 93.7 (93.5 to 93.9)
Occupational therapist 
24 h 50.5 (48.8 to 52.2) 61.2 (59.6 to 62.8) 79.4 (78.1 to 80.6) 45.2 (44.7 to 45.6) 47.5 (47.1 to 47.9) 52.3 (51.9 to 52.7)
Occupational therapist 
72 h 94.4 (93.6 to 95.1) 96.4 (95.8 to 97.0) 96.9 (96.4 to 97.4) 87.3 (87.1 to 87.6) 88.5 (88.2 to 88.7) 89.7 (89.4 to 89.9)
SaLT swallow 24 h 53.2 (50.8 to 55.6) 56.9 (54.4 to 59.4) 55.7 (53.1 to 58.2) 48.4 (47.8 to 49.0) 49.9 (49.3 to 50.5) 54.0 (53.4 to 54.6)
SaLT swallow 72 h 94.0 (93.6 to 94.4) 85.5 (83.9 to 87.2) 91.3 (89.9 to 92.7) 91.9 (90.6 to 93.3) 78.8 (78.3 to 79.3) 82.2 (81.7 to 82.6) 84.9 (84.5 to 85.3)
SaLT communication 
24 h 39.7 (37.3 to 42.2) 53.8 (51.5 to 56.2) 69.9 (68.0 to 71.7) 35.5 (34.9 to 36.1) 38.0 (37.5 to 38.6) 42.0 (41.5 to 42.6)
SaLT communication 
72 h 86.7 (85.1 to 88.3) 93.4 (92.2 to 94.5) 96.6 (95.9 to 97.3) 78.3 (77.8 to 78.7) 81.6 (81.2 to 82.0) 85.1 (84.7 to 85.5)
SaLT=speech and language therapist; SU=stroke unit; tPA=tissue plasminogen activator. 
*Refers to data from period 2010-12.20
See supplementary material for graphical depiction.
Table 4 | Adjusted between region difference-in-differences in risk adjusted length of acute hospital stay (Greater Manchester versus rest of England, 
controlling for London)
Type of stroke
Rest of England Greater Manchester Difference-in-differences (95% CI): Greater Manchester v rest of 
EnglandBefore After Before After
All stroke subtypes 19.7 15.7 19.6 13.2 −1.5 (−2.5 to −0.4)
Intracerebral haemorrhage (I61*) 19.8 16.9 19.7 15.9 −1.2 (−3.3 to 1.0)
Cerebral infarction (I63*) 20.4 16.2 21.0 13.5 −1.3 (−2.4 to −0.2)
Stroke, not specified as haemorrhage or infarction (I64*) 15.9 12.0 15.0 11.6 −4.4 (−7.0 to −1.8)
Values in difference-in-differences columns are absolute differences in risk adjusted length of acute hospital stay showing change over time in Greater Manchester minus change over time in rest 
of England (see text). Values in preceding columns show absolute risk adjusted length of hospital stay in rest of England and Greater Manchester. To estimate these, separate models were run for 
rest of England and Greater Manchester. Patient level data were used to regress length of hospital stay against sex and age interactions, stroke diagnosis using first four digits of primary ICD-10 
diagnostic code, number of comorbidities derived from secondary ICD-10 diagnostic codes, presence of 16 comorbidities based on ICD-10 chapter headings derived from secondary ICD-10 
diagnostic codes, ethnic group, fifth of deprivation, hospital and calendar month, mortality at 3, 30, and 90 days, plus indicator variables for whether patient was admitted before or after April 
2015 reconfiguration in Greater Manchester; predictive margins for this indicator variable are shown in table. Values in difference-in-differences columns do not equal differences in absolute risk 
adjusted length of hospital stay in preceding columns: with statistical method used to estimate difference-in-differences (see text), it is not possible to recover absolute risk adjusted length of 
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“case for greater concentration of care,” associated 
guidance on transforming urgent and emergency care 
services across the English NHS, and the National 
Clinical Strategy for Scotland 2016.19 39-41 Our 
findings on clinical interventions have been cited in 
the 2016 edition of the National Clinical Guidance 
for Stroke as evidence of the benefits of stroke service 
reorganisation.20 42 On the basis of the experiences 
in London and Greater Manchester, several areas of 
the UK (including both urban and more rural areas) 
are considering system-wide reconfiguration of acute 
stroke services and have cited our earlier research in 
“case for change” documents; these areas include 
Yorkshire and the Humber; Birmingham, Solihull, and 
the Black Country; Sussex; Kent and Medway; South 
West England; and Cumbria.43-49 Our methods and 
findings may also inform the centralisation of other 
healthcare services such as cancer care,50 51 cardiac 
arrest/myocardial infarction,52-54 major trauma care,55 
and vascular surgery,56 for which evidence of impact 
is growing.
Unanswered questions and future research
Given that we could analyse data only for patients 
treated up to one year after the second centralisation 
in Greater Manchester, and the fact that SSNAP data 
indicate that the proportion of patients treated in 
a HASU and receiving clinical interventions has 
continued to increase in Greater Manchester,32 further 
research on the longer term effects of the second 
reconfiguration in Greater Manchester would be 
beneficial. Future research would also be beneficial 
to examine effects on disability and dependence after 
stroke, as well as how and why the improvements seen 
in London were sustained over time. Given the results 
of this and our previous study, further research would 
be helpful to understand how to further improve access 
to HASU care for all stroke patients. In April 2017 NHS 
England announced that it will begin commissioning 
mechanical thrombectomy for patients with certain 
types of acute ischaemic stroke.57 Further work to 
evaluate the effect of introducing these services into 
the NHS, and how they ought to be organised, would 
be useful.
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Table 6 | Adjusted percentages of patients receiving clinical interventions in London by year. Values are predictive 
margins
Intervention Ramsay* 2013/14 2014/15 2015/16
Brain scan within 60 min 57.3 (56.2 to 58.3) 58.9 (57.9 to 60.0) 59.9 (58.8 to 61.0)
Brain scan within 180 min 66.3 (65.6 to 67.1) 80.0 (79.1 to 80.9) 81.8 (81.0 to 82.6) 82.2 (81.4 to 83.1)
Brain scan within 24 h 95.2 (94.8 to 95.5) 97.2 (96.9 to 97.6) 97.1 (96.8 to 97.5) 97.3 (97.0 to 97.7)
tPA to eligible patients 92.9 (91.6 to 94.2) 94.4 (93.2 to 95.7) 88.6 (86.9 to 90.3)
tPA within 60 min 83.0 (81.0 to 85.0) 83.9 (81.9 to 85.9) 80.8 (78.6 to 83.1)
Swallow screen within 4 h 65.1 (64.1 to 66.2) 68.1 (67.1 to 69.2) 70.6 (69.6 to 71.6)
Admitted to SU within 4 h 66.3 (65.6 to 67.1) 61.1 (60.0 to 62.1) 59.8 (58.7 to 60.8) 60.3 (59.2 to 61.3)
Consultant assessment 14 h 50.3 (49.2 to 51.5) 53.7 (52.6 to 54.8) 51.3 (50.1 to 52.4)
Consultant assessment 24 h 89.3 (88.6 to 90.0) 90.2 (89.6 to 90.9) 88.5 (87.8 to 89.2)
Stroke nurse assessment 12 h 90.8 (90.1 to 91.4) 92.7 (92.1 to 93.2) 93.3 (92.7 to 93.8)
Stroke nurse assessment 24 h 95.5 (95.1 to 96.0) 95.6 (95.2 to 96.1) 96.2 (95.7 to 96.6)
Physiotherapist assessment 24 h 57.4 (56.2 to 58.5) 61.7 (60.5 to 62.8) 64.7 (63.6 to 65.8)
Physiotherapist assessment 72 h 95.4 (95.0 to 95.8) 95.0 (94.5 to 95.5) 96.5 (96.0 to 96.9) 95.8 (95.3 to 96.2)
Occupational therapist 24 h 50.3 (49.1 to 51.4) 57.0 (55.8 to 58.1) 61.5 (60.3 to 62.6)
Occupational therapist 72 h 91.1 (90.5 to 91.8) 94.6 (94.1 to 95.1) 94.1 (93.6 to 94.7)
SaLT swallow 24 h 53.9 (52.2 to 55.7) 54.1 (52.5 to 55.8) 51.5 (49.8 to 53.3)
SaLT swallow 72 h 98.2 (97.9 to 98.4) 89.5 (88.5 to 90.6) 91.8 (90.9 to 92.7) 88.4 (87.3 to 89.5)
SaLT communication 24 h 46.4 (45.0 to 47.8) 50.1 (48.7 to 51.5) 50.7 (49.2 to 52.1)
SaLT communication 72 h 89.7 (88.8 to 90.5) 93.0 (92.3 to 93.7) 91.0 (90.2 to 91.8)
SaLT=Speech and Language Therapist; SU=stroke unit; tPA=tissue plasminogen activator.
*Refers to data from period 2010-12.20
See supplementary figures A-C for graphical depiction.
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